| 发明名称 |
NOVEL TRIAZINE DERIVATIVE |
| 摘要 |
To provide a novel triazine derivative represented by the following formula (I):
A triazine derivative represented by the following formula (I):;;wherein
R1 represents a substituted or unsubstituted aryl group, a substituted or unsubstituted heterocyclic ring, a substituted or unsubstituted heterocyclic fused ring, or a substituted or unsubstituted alkynyl group,R2 represents a hydrogen atom, a halogen atom, a substituted or unsubstituted lower alkyl group, or a substituted or unsubstituted alkoxy group,R3 represents a substituted or unsubstituted aryl group, a substituted or unsubstituted heterocyclic ring, or a substituted or unsubstituted heterocyclic fused ring,R4 represents a hydrogen atom, a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted alkoxy group, a substituted or unsubstituted amino group, or a halogen atom, andR5 represents a hydrogen atom, a substituted or unsubstituted lower alkyl group, or R1 and R5 may be combined to form a saturated or unsaturated 5- to 6-membered ring, thereby forming a multiply fused ring,
or a pharmaceutically acceptable salt thereof. |
| 申请公布号 |
US2015011751(A1) |
申请公布日期 |
2015.01.08 |
| 申请号 |
US201314383860 |
申请日期 |
2013.03.07 |
| 申请人 |
CARNA BIOSCIENCES, INC. |
发明人 |
Kawahata Wataru;Asami Tokiko;Sawa Masaaki;Asamitsu Yuko;Irie Takayuki;Miyake Takahiro;Kiyoi Takao |
| 分类号 |
C07D513/04;C07D401/14;C07D251/22;C07D401/12;C07D409/12;C07D413/14;C07D405/12;C07D487/04;C07D417/12;C07D251/18;C07D403/10 |
主分类号 |
C07D513/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A triazine derivative represented by the following formula (I): wherein R1 represents a substituted or unsubstituted aryl group, a substituted or unsubstituted heterocyclic ring, a substituted or unsubstituted heterocyclic fused ring, or a substituted or unsubstituted alkynyl group, R2 represents a hydrogen atom, a halogen atom, a substituted or unsubstituted lower alkyl group, or a substituted or unsubstituted alkoxy group, R3 represents a substituted or unsubstituted aryl group, a substituted or unsubstituted heterocyclic ring, or a substituted or unsubstituted heterocyclic fused ring, R4 represents a hydrogen atom, a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted alkoxy group, a substituted or unsubstituted amino group, or a halogen atom, and R5 represents a hydrogen atom, a substituted or unsubstituted lower alkyl group, or R1 and R5 may be combined to form a saturated or unsaturated 5- to 6-membered ring, thereby forming a multiply fused ring, or a pharmaceutically acceptable salt thereof. |
| 地址 |
Kobe-shi, Hyogo JP |
